Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy

Epilepsy Research

Volumn 108, Issue 6, 2014, Pages 1128-1136

  Wechsler, Robert T ^a   Leroy, Robert ^b   Van Cott, Anne ^c   Hammer, Anne E ^d   Vuong, Alain ^d   Huffman, Russell ^d   VanLandingham, Kevan ^d   Messenheimer, John A ^d  

^a Idaho Comprehensive Epilepsy Center   (United States)

^b Texas Epilepsy Group   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Elderly; Epilepsy; Extended release; Lamotrigine; Monotherapy

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; ANTICONVULSIVE AGENT; DELAYED RELEASE FORMULATION; TRIAZINE DERIVATIVE;

ADJUVANT THERAPY; AGED; ANEMIA; ARTHRALGIA; ARTICLE; ATAXIA; BACKACHE; BALANCE DISORDER; COMPLEX PARTIAL SEIZURE; CONFUSION; CONSTIPATION; CONTUSION; CONVULSION; DECREASED APPETITE; DIARRHEA; DISEASE CLASSIFICATION; DIZZINESS; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; EPILEPTIC STATE; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GAIT DISORDER; HEADACHE; HIP FRACTURE; HUMAN; LACERATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORBIDITY; MUSCLE WEAKNESS; MYALGIA; MYOCLONUS SEIZURE; NAUSEA; OPEN STUDY; PAIN; PERIPHERAL EDEMA; PRIORITY JOURNAL; PRURITUS; RASH; RHINOPHARYNGITIS; SIMPLE PARTIAL SEIZURE; SOMNOLENCE; TONIC CLONIC SEIZURE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; TREMOR; URINARY TRACT INFECTION; VAGUS NERVE STIMULATION; VOMITING; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; DRUG COMBINATION; PATHOPHYSIOLOGY; SEIZURES; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; SEIZURES; TREATMENT OUTCOME; TRIAZINES;

EID: 84902250496     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2014.04.009     Document Type: Article

References (41)

1. Arain A.M., Abou-Khalil B.W. Management of new-onset epilepsy in the elderly. Nat. Rev. Neurol. 2009, 5:363-371.
2. Atkinson M.J., Sinha A., Hass S.L., et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM) using a national panel study of chronic disease. Health Qual. Life Outcomes 2004, 2:12-25.
3. Beck A.T., Steer R.A., Ball R., et al. Comparison of Beck Depression Inventories IA and II in psychiatric outpatients. J. Pers. 1996, 67:588-597.
4. Bergey G.K. Initial treatment of epilepsy: special issues in treating the elderly. Neurology 2004, 63(10 (Suppl. 4)):S40-S48.
5. Biton V., DiMemmo J., Shukla R., et al. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study. Epilepsy Behav. 2010, 19:352-358.
6. Blaszczyck B., Czuczwar S.J. Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients. Neuropsychiatr. Dis. Treat. 2010, 6:145-150.
7. Brodie M.J., Overstall P.W., Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res. 1999, 37:81-87.
8. Brodie M.J., Elder A.T., Kwan P. Epilepsy in later life. Lancet Neurol. 2009, 8:1019-1030.
9. Buck D., Jacoby A., Baker G.A., Chadwick D.W. Factors influencing compliance with antiepileptic drug regimes. Seizure 1997, 6:87-93.
10. Claxton A.J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 2001, 23:1296-1310.
11. Cramer J., Vachon L., Desforges C., et al. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995, 36:1111-1117.
12. Cramer J.A., Glassman M., Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav. 2002, 3:228-242.
13. Culy C.R., Goa K.L. Lamotrigine: a review of its use in childhood epilepsy. Paediatr. Drugs 2000, 2:299-330.
14. Doughty J., Baker G.A., Jacoby A., et al. Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy. Epilepsy Behav. 2003, 4:710-716.
15. Ettinger A.B., Manjunath R., Candrilli S.D., et al. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav. 2009, 14:324-329.
16. French J.A., Temkin N., Shneker B.F., Lamotrigine X.R., et al. conversion to monotherapy: first study using a historical control group. Neurotherapeutics 2012, 9:176-184.
17. Garnett W.R. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy 2000, 20:191S-199S.
18. Johnston A., Smith P.E. Epilepsy in the elderly. Expert Rev. Neurother. 2010, 10:1899-1910.
19. LAMICTAL XR (lamotrigine) Extended-Release Tablets prescribing information 2011, September, GlaxoSmithKline, Available at: http://www.gsk.com/products/prescription-medicines/lamictal.htm (accessed 25.10.11).
20. LAMICTAL (lamotrigine tablets) prescribing information 2011, September, GlaxoSmithKline, Available at: http://www.gsk.com/products/prescription-medicines/lamictal.htm (accessed 25.10.11).
21. Leppik I.E., Birnbaum A.K. Epilepsy in the elderly. Ann. N. Y. Acad. Sci. 2010, 1184:208-224.
22. Lott R.S. Lamotrigine: treatment of epilepsy in the elderly. Consult. Pharm. 2003, 18:979-992.
23. Malik S., Arif H., Hirsch L.J. Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders. Expert Rev. Neurother. 2006, 6:1609-1627.
24. Marasco R.A., Ramsay R.E. Managing epilepsy: issues in the elderly. Consult. Pharm. 2009, 24(Suppl. A):17-22.
25. McGahuey C.A., Gelenberg A.J., Laukes C.A., et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J. Sex. Marital Ther. 2000, 26:25-40.
26. Messenheimer J., Mullens E.L., Giorgi L., et al. Safety review of adult clinical trial experience with lamotrigine. Drug Saf. 1998, 18:281-296.
27. Naritoku D.K., Warnock C.R., Messenheimer J.A., et al. Lamotrigine extended-release as adjunctive therapy for partial seizures. Neurology 2007, 69:1610-1618.
28. Nielsen K.A., Dehl M., Tommerup D., et al. Diurnal lamotrigine plasma level fluctuations: clinical significance and indication of shorter half-life with chronic administration. Epilepsy Behav. 2008, 13:470-473.
29. Ramsay R.E., Rowan A.J., Pryor F.M. Special considerations in treating the elderly patient with epilepsy. Neurology 2004, 62(5 (Suppl. 2)):S24-S29.
30. Rheims S., Ryvlin P. Once-daily lamotrigine extended release for epilepsy management. Expert Rev. Neurother. 2009, 9:167-173.
31. Rowan A.J., Ramsay R.E., Collins J.F., et al. New-onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005, 64:1868-1873.
32. Saetre E., Perucca E., Isojarvi J., et al. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007, 48:1292-1302.
33. Sajatovic M., Ramsay E., Nanry K., et al. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. Int. J. Geriatr. Psychiatry 2007, 22:945-950.
34. Sanya E.O. Peculiarity of epilepsy in elderly people: a review. West Afr. J. Med. 2010, 29:365-372.
35. Steinbaugh L., Szaflarski J.P. Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine. Drug Des. Dev. Ther. 2010, 4:337-342.
36. Tompson D.J., Ali I., Oliver-Willwong R., et al. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study). Epilepsia 2008, 49:410-417.
37. Valencia I., Pinol-Ripoll G., Khurana D.S., et al. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Eur. J. Paediatr. Neurol. 2009, 13:141-145.
38. Werhahn K.J. Epilepsy in the elderly. Dtsch. Arztebl. Int. 2009, 106:135-142.
39. Werz M.A. Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release. Ther. Clin. Risk Manage. 2008, 4:1035-1046.
40. Williams J., Lawthom C., Dunstan F.D., et al. Variability of antiepileptic medication-taking behaviour in sudden unexplained death in epilepsy: hair analysis at autopsy. J. Neurol. Neurosurg. Psychiatry 2006, 77:481-484.
41. Zeber J.E., Copeland L.A., Pugh M.J. Variation in antiepileptic drug adherence among older patients with new-onset epilepsy. Ann. Pharmacother. 2010, 44:1896-1904.